Literature DB >> 18392798

[Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance?].

M May1, R Kalisch, B Hoschke, T Juretzek, F Wagenlehner, S Brookman-Amissah, I Spivak, K-P Braun, W Bär, C Helke.   

Abstract

BACKGROUND: Human papillomaviruses (HPV) are the most frequent pathogens of sexually transmitted diseases. They have been associated with an increased incidence of several anogenital tumors. Whether oncogenic HPV are involved in the pathogenesis of prostate cancer has been a subject of great controversy. This study's purpose was to investigate the association between HPV infection and prostate cancer (PCA).
MATERIAL AND METHODS: The study included 213 consecutive patients with an average age of 65.7 (+/-8.4) years. Within the framework of transrectal, ultrasonic-guided multibiopsy of the prostate, one additional core was examined by means of polymerase chain reaction (PCR) in relation to bacterial, fungal, and viral (including HPV) DNA, with subsequent DNA sequencing. The collected data were correlated with the histological results and with diverse clinical variables. The influence of several predictors for the existence of PCA was verified with a logistic regression model.
RESULTS: No general bacterial DNA (16S rDNA) was detected. Of the 213 patients, 145 (68.1%) showed HPV DNA. In 64% (n=137), high-risk HPV DNA were depicted; these were 18% of the total in each case of HPV genotypes 16 and 18. From our examinations, no significant positive correlation existed between the HPV evidence and the histologically verified PCA that was found in 23.5% of the patients (n=50; odds ratio 1.45; 95% confidence interval 0.71-2.91). The BK virus was not found in any of the cores confirmed through PCR.
CONCLUSION: Although no positive correlation between HPV infection and PCA existed in our study, data from the literature suggest an influence of the papillomavirus on PCA oncogenesis. Future studies should highlight to what extent HPV DNA is inserted in the genome of prostate cells and is able to cause subsequent malignant transformation of particular genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392798     DOI: 10.1007/s00120-008-1694-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  37 in total

1.  HPV vaccination--more answers, more questions.

Authors:  George F Sawaya; Karen Smith-McCune
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

2.  Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer.

Authors:  J Dillner; P Knekt; J Boman; M Lehtinen; V Af Geijersstam; M Sapp; J Schiller; J Maatela; A Aromaa
Journal:  Int J Cancer       Date:  1998-02-09       Impact factor: 7.396

3.  Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections.

Authors:  Alberto Zambrano; Mina Kalantari; Anne Simoneau; Jerald L Jensen; Luis P Villarreal
Journal:  Prostate       Date:  2002-12-01       Impact factor: 4.104

Review 4.  The role of human papillomavirus infection in prostate cancer.

Authors:  Jaudah A Al-Maghrabi
Journal:  Saudi Med J       Date:  2007-03       Impact factor: 1.484

5.  Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization.

Authors:  S Masood; R M Rhatigan; S Powell; J Thompson; N Rodenroth
Journal:  South Med J       Date:  1991-02       Impact factor: 0.954

6.  Detection and expression of human BK virus sequences in neoplastic prostate tissues.

Authors:  Dweepanita Das; Rajal B Shah; Michael J Imperiale
Journal:  Oncogene       Date:  2004-09-16       Impact factor: 9.867

7.  Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway.

Authors:  M T McCabe; J A Low; M J Imperiale; M L Day
Journal:  Oncogene       Date:  2006-05-04       Impact factor: 9.867

8.  Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization.

Authors:  G K Ibrahim; P E Gravitt; K L Dittrich; S N Ibrahim; O Melhus; S M Anderson; C N Robertson
Journal:  J Urol       Date:  1992-12       Impact factor: 7.450

9.  Detection of human papillomavirus 16 transcription in human prostate tissue.

Authors:  J G Dodd; M Paraskevas; P J McNicol
Journal:  J Urol       Date:  1993-02       Impact factor: 7.450

10.  Prostate cancer.

Authors:  David F Penson; June M Chan
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  5 in total

1.  Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis.

Authors:  Y Lin; Q Mao; X Zheng; K Yang; H Chen; C Zhou; L Xie
Journal:  Ir J Med Sci       Date:  2011-03-12       Impact factor: 1.568

2.  [Association between residual urinary volume and urinary tract infection: prospective trial in 225 male patients].

Authors:  S Brookman-May; M Burger; B Hoschke; W F Wieland; F Kendel; C Gilfrich; K-P Braun; M May
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

3.  Polyomavirus BK and prostate cancer: an unworthy scientific effort?

Authors:  Pasquale Ferrante; Maurizio Provenzano; Serena Delbue
Journal:  Oncoscience       Date:  2014-04-30

4.  Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2015-02-11

5.  Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients.

Authors:  Oliver Hohn; Hans Krause; Pia Barbarotto; Lars Niederstadt; Nadine Beimforde; Joachim Denner; Kurt Miller; Reinhard Kurth; Norbert Bannert
Journal:  Retrovirology       Date:  2009-10-16       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.